| Financial Year |
March 31 2023 |
| Monetary Funds |
526,300,491.81 |
| Held-for-trading Financial Assets |
195,570,588.25 |
| Notes Receivable |
6,146,200.51 |
| Accounts Receivable |
726,921,437.50 |
| Advances to Suppliers |
58,617,776.01 |
| Other Receivables |
37,014,728.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
258,539,301.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
55,596,087.97 |
| Total Current Assets |
1,880,031,773.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,593,188.04 |
| Investment Properties |
-- |
| Fixed Assetes |
194,790,997.95 |
| Under-construction Projects |
87,881,858.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
135,563,230.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
28,258,694.22 |
| Deferred Income Tax Assets |
15,548,253.86 |
| Other Non-Current Assets |
657,991.10 |
| Sub-Total of Non-Current Assets |
491,789,177.95 |
| Total Assets |
2,371,820,951.19 |
| Short-Term Loans |
100,113.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
71,258,687.04 |
| Accounts Payable |
360,522,054.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,181,860.83 |
| Taxes Payable |
53,247,500.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
81,078,214.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,041,225.89 |
| Other Current Liabilities |
25,348,556.93 |
| Sub-Total of Current Liabilities |
767,996,048.57 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,232,497.63 |
| Total Liabilities |
779,228,546.20 |
| Paid-In Capital(Or Share Stock) |
410,640,000.00 |
| Capital Surplus |
689,975,979.62 |
| Surplus Reserve |
103,906,024.46 |
| LESS:Treasury Stock |
74,622,600.00 |
| Undistributed Profits |
438,880,450.16 |
| Minority Stockholder's Interest |
23,825,655.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,568,766,749.70 |
| Owner's Equity（Stockholder's Equity） |
1,592,592,404.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,371,820,951.19 |
